Tuberculosis(TB)is an infectious diseases with substantial morbidity and mortality worldwide.Drug-sensitive TB requires at least 6 months of anti-tuberculosis treatment,while the traditional course for multidrug-resistant tuberculosis(MDR-TB)is much longer.Therefore,to promote significant improvement in TB management and disease control,short-course TB treatment has become a research focus in recent years.This article reviews the current progress of short-course treatment of pulmonary tuberculosis.
维普
万方数据